Glenda E. Gray

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines”.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

PLoS Medicine(2022)10.1371/journal.pmed.1004024

N/A

0.961DataRank · unranked

21 citations

Azwidihwi Takalani, Ishen Seocharan, Nonhlanhla Yende‐Zuma, Tarylee Reddy, Imke Engelbrecht +23 more

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns

medRxiv(2024)10.1101/2024.10.15.24315548

N/A

0.299DataRank · unranked

2 citations

Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen, Deirdre Josipovic, Vuyelwa Baba +18 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

medRxiv(2023)10.1101/2023.11.20.23298785

N/A

0DataRank · unranked

5 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

PLOS Global Public Health(2024)10.1371/journal.pgph.0002703

N/A

0DataRank · unranked

12 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more